Indo Healthcare Formulations Pvt Ltd (IHFPL) specializes as a Contract Development and Manufacturing Organization, offering technology transfer, novel drug delivery systems (NDDS), loan licensing, and technical collaborations with DCGI approvals for first-time launches in India.
IHFPL's vision and mission drive our focus on quality manufacturing, regulatory excellence, and strategic collaborations to deliver impactful healthcare solutions.
To be India’s premier CDMO, pioneering novel drug delivery systems and DCGI-approved formulations through cutting-edge technology and global partnerships.
Provide end-to-end CDMO services, including technology transfer, loan licensing, and customized manufacturing to ensure reliable, high-quality pharmaceutical solutions for our clients.
From technology transfer to custom packaging, IHFPL supports your formulation needs with regulatory expertise and manufacturing flexibility.
End-to-end CDMO services for tablets, capsules, ointments, and sachets across 20+ therapeutic areas.
Seamless process transfer with DCGI-approved protocols for efficient scale-up.
Flexible licensing arrangements for market entry and distribution.
Advanced NDDS including SR/ER, bilayered tablets, and dispersible formulations.
Strategic joint ventures and partnerships for innovative launches.
IHFPL manufactures 350+ formulations organized into specialized categories for comprehensive healthcare solutions.
Advanced formulations with SR/ER, bilayered, and dispersible options for optimal delivery across antibiotics, cardiovascular, diabetic, and CNS therapies.
Targeted topical solutions for analgesic, anti-inflammatory, antifungal, and dermatological applications.
Precision-filled capsules including anti-coagulants, antibiotics, and neuropathic pain formulations with controlled release technology.
Convenient single-dose powders for gynecology, pediatrics, probiotics, and oral rehydration needs.
Choose IHFPL for proven CDMO expertise, regulatory compliance, and customized solutions that accelerate your market success.
Common queries about our CDMO services, capabilities, and processes.
IHFPL operates as a Contract Development and Manufacturing Organization (CDMO) specializing in technology transfer, loan licensing, and novel formulations.
Tablets, capsules, ointments/creams, and sachets across 20+ therapeutic categories with 350+ formulations.
Yes, we provide flexible packaging, including Alu-Alu, Blister (10x10, 10x15), Strips, and client-specific configurations.
DCGI approvals for novel and first-time launches in India, ensuring cGMP-compliant processes.
Yes, we specialize in seamless technology transfer for efficient scale-up and commercialization.
Antibiotics, cardiovascular, diabetic, CNS, musculoskeletal, gynecology, dermatology, and more.
Yes, including NDDS, SR/ER formulations, bilayered tablets, and dispersible formats.
Through contract manufacturing, loan licensing, technical collaborations, or joint ventures.